These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22007842)

  • 1. Better evidence for safety and efficacy is needed before neurologists prescribe drugs for neuroenhancement to healthy people.
    Boot BP; Partridge B; Hall W
    Neurocase; 2012 Jun; 18(3):181-4. PubMed ID: 22007842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroenhancement in healthy subject? A French case study].
    Micoulaud-Franchi JA; Vion-Dury J; Lancon C
    Therapie; 2012; 67(3):213-21. PubMed ID: 22874487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive neuroenhancement: false assumptions in the ethical debate.
    Heinz A; Kipke R; Heimann H; Wiesing U
    J Med Ethics; 2012 Jun; 38(6):372-5. PubMed ID: 22228818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety, and ethics of cosmetic neurology far from settled.
    Flower K; Li L; Chen CY; Baggott MJ; Galloway GP; Mendelson J
    Clin Pharmacol Ther; 2010 Oct; 88(4):461-3. PubMed ID: 20856245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications.
    Graf WD; Nagel SK; Epstein LG; Miller G; Nass R; Larriviere D
    Neurology; 2013 Mar; 80(13):1251-60. PubMed ID: 23486879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responding to requests from adult patients for neuroenhancements: guidance of the ethics, law and humanities committee.
    Racine E; Forlini C
    Neurology; 2010 May; 74(19):1555-6; author reply 1556. PubMed ID: 20458078
    [No Abstract]   [Full Text] [Related]  

  • 7. [Options, limits and ethics of pharmacological neuroenhancement].
    Normann C; Boldt J; Maio G; Berger M
    Nervenarzt; 2010 Jan; 81(1):66-74. PubMed ID: 19851745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee.
    Larriviere D; Williams MA; Rizzo M; Bonnie RJ;
    Neurology; 2009 Oct; 73(17):1406-12. PubMed ID: 19776378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What should we do about student use of cognitive enhancers? An analysis of current evidence.
    Ragan CI; Bard I; Singh I;
    Neuropharmacology; 2013 Jan; 64():588-95. PubMed ID: 22732441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroenhancement: wisdom of the masses or "false phronesis"?
    Larriviere D; Williams MA
    Clin Pharmacol Ther; 2010 Oct; 88(4):459-61. PubMed ID: 20856244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. True and false concerns about neuroenhancement: a response to 'Neuroenhancers, addiction and research ethics', by D M Shaw.
    Heinz A; Kipke R; Müller S; Wiesing U
    J Med Ethics; 2014 Apr; 40(4):286-7. PubMed ID: 23468510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroenhancers, addiction and research ethics.
    Shaw DM
    J Med Ethics; 2012 Oct; 38(10):605-8. PubMed ID: 22888151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive enhancement in children and adolescents: is it in their best interests?
    Gaucher N; Payot A; Racine E
    Acta Paediatr; 2013 Dec; 102(12):1118-24. PubMed ID: 24033708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical issues in the use of cognitive enhancement.
    Darby R
    Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(2):16-22. PubMed ID: 20455376
    [No Abstract]   [Full Text] [Related]  

  • 15. Cognitive enhancement: promises and perils.
    Hyman SE
    Neuron; 2011 Feb; 69(4):595-8. PubMed ID: 21338872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Doctor, would you prescribe a pill to help me … ?" a national survey of physicians on using medicine for human enhancement.
    Hotze TD; Shah K; Anderson EE; Wynia MK
    Am J Bioeth; 2011 Jan; 11(1):3-13. PubMed ID: 21240795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The perils of failing to enhance: a response to Persson and Savulescu.
    Fenton E
    J Med Ethics; 2010 Mar; 36(3):148-51. PubMed ID: 20211993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology.
    Cakic V
    J Med Ethics; 2009 Oct; 35(10):611-5. PubMed ID: 19793941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment strategies of residential primary care providers in dementia diseases--results of a representative survey in western Austria.
    Gurka P; Bacher R; Kemmler G; Hinterhuber H; Lingg A; Marksteiner J
    Pharmacopsychiatry; 2002 Jul; 35(4):144-9. PubMed ID: 12163984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smart drugs "as common as coffee": media hype about neuroenhancement.
    Partridge BJ; Bell SK; Lucke JC; Yeates S; Hall WD
    PLoS One; 2011; 6(11):e28416. PubMed ID: 22140584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.